Previous close | 121.71 |
Open | 120.93 |
Bid | 120.71 x 1100 |
Ask | 120.77 x 900 |
Day's range | 120.51 - 121.41 |
52-week range | 102.00 - 149.25 |
Volume | |
Avg. volume | 1,382,748 |
Market cap | 24.808B |
Beta (5Y monthly) | 1.02 |
PE ratio (TTM) | 24.74 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.96 (0.79%) |
Ex-dividend date | 27 Mar 2024 |
1y target est | N/A |
Besides Wall Street's top -and-bottom-line estimates for Zimmer (ZBH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
Baxter's (BAX) first-quarter results are likely to reflect growth in elective surgical procedures and a more stable supply chain.
Zimmer (ZBH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.